The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2020

Filed:

Aug. 30, 2017
Applicant:

University of Pittsburgh-of the Commonwealth System of Higher Education, Pittsburgh, PA (US);

Inventors:

Edwin K. Jackson, Pittsburgh, PA (US);

Stevan P. Tofovic, Pittsburgh, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/708 (2006.01); A61K 31/522 (2006.01); A61P 7/00 (2006.01); A61P 3/10 (2006.01); A61P 11/00 (2006.01); A61P 7/02 (2006.01); A61K 45/06 (2006.01); A61P 25/28 (2006.01); A61K 31/4965 (2006.01); A61P 31/18 (2006.01); A61P 9/12 (2006.01); A61P 9/04 (2006.01); A61P 13/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/708 (2013.01); A61K 31/4965 (2013.01); A61K 31/522 (2013.01); A61K 45/06 (2013.01); A61P 3/10 (2018.01); A61P 7/00 (2018.01); A61P 7/02 (2018.01); A61P 9/04 (2018.01); A61P 9/12 (2018.01); A61P 11/00 (2018.01); A61P 13/00 (2018.01); A61P 25/28 (2018.01); A61P 31/18 (2018.01);
Abstract

Herein, 8-substituted guanine and/or 8-substituted guanosine compounds are used in methods to treat hypertension (such as systemic or pulmonary hypertension), stroke, diabetes, and/or patients in need of a diuretic. In addition, 8-substituted guanine and/or 8-substituted guanosine compounds are included in a beverage composition, which can be a fermented beverage, such as wine. Further, purine nucleoside phosphorylase (PNPase) inhibitors (such as 8-substituted guanine and/or 8-substituted guanosine) and/or PNPase purine nucleoside substrates (such as guanosine and/or inosine) can be used in methods of treating or reducing the risk of pulmonary hypertension (PH), such as PH associated with HIV or sickle cell disease (SCD). PNPase inhibitors (such as 8-substituted guanine and/or 8-substituted guanosine) and/or PNPase purine nucleoside substrates (such as guanosine and/or inosine) can also be used in methods of treating SCD or reducing sickling of red blood cells (RBCs).


Find Patent Forward Citations

Loading…